NASDAQ: ACTUActuate Therapeutics Inc Stock Ownership - Who owns Actuate Therapeutics?
Insider buying vs selling
Have Actuate Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel M. Schmitt | President CEO and Director | 2026-02-13 | 121,874 | $4.33 | $527.71kSell |
| Todd S. Thomson | Director | 2026-01-05 | 280,000 | $5.80 | $1.62MSell |
| Bios Equity Cof LP | Director | 2025-06-27 | 71,428 | $7.00 | $500.00kBuy |
| Aaron Gl Fletcher | Director | 2025-06-27 | 71,428 | $7.00 | $500.00kBuy |
| Leslie W. Kreis | Director | 2025-06-27 | 71,428 | $7.00 | $500.00kBuy |
ACTU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACTU insiders and whales buy or sell their stock.
ACTU Shareholders
What type of owners hold Actuate Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Leslie W. Kreis | 42.62% | 10,196,456 | $20.70M | Insider |
| Aaron Gl Fletcher | 42.62% | 10,196,456 | $20.70M | Insider |
| Bios Equity Cof LP | 42.62% | 10,196,456 | $20.70M | Insider |
| Bios Capital Management LP | 42.00% | 10,049,996 | $20.40M | Institution |
| Todd S. Thomson | 9.84% | 2,354,344 | $4.78M | Insider |
| Voss Capital LP | 7.21% | 1,725,000 | $3.50M | Institution |
| Daniel M. Schmitt | 3.26% | 780,921 | $1.59M | Insider |
| Blackrock Inc | 1.79% | 427,153 | $867.12k | Institution |
| Vanguard Capital Management LLC | 1.67% | 400,529 | $813.07k | Institution |
| Geode Capital Management LLC | 0.95% | 228,331 | $463.51k | Institution |
ACTU vs Biotech Stocks
Actuate Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.